SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-15-023875
Filing Date
2015-04-20
Accepted
2015-04-20 17:24:37
Documents
9
Period of Report
2015-04-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A v407557_pre14a.htm PRE 14A 1097302
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_novavax-tag.jpg GRAPHIC 108920
4 GRAPHIC logo_novavax.jpg GRAPHIC 39085
5 GRAPHIC sig_john-herrmann3.jpg GRAPHIC 14491
6 GRAPHIC sig_stanley-erck.jpg GRAPHIC 20134
7 GRAPHIC spacer.gif GRAPHIC 43
8 GRAPHIC v407557_proxycrd01.jpg GRAPHIC 232576
9 GRAPHIC v407557_proxycrd02.jpg GRAPHIC 144789
  Complete submission text file 0001144204-15-023875.txt   1871169
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-26770 | Film No.: 15781342
SIC: 2836 Biological Products, (No Diagnostic Substances)